News
Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...
Quest Diagnostics Inc. closed 8.75% short of its 52-week high of $182.38, which the company achieved on June 16th.
Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full ...
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...
Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...
However, Waters has announced plans to merge with BD's life science and diagnostics segment in early 2026, which will dilute that interest in that highly regulated end market, going forward. The ...
The global Esoteric Testing Market is valued at USD 30.56 billion in 2024 and is projected to reach a value of USD 84.12 ...
DGX stock surges 27.3% in a year, fueled by Advanced Diagnostics, key acquisitions and expanding health plan ties.
13dOpinion
Zacks Investment Research on MSN4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health SpaceThe Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare ...
DGX rides on double-digit diagnostics growth and a wave of strategic acquisitions despite rising debt and policy headwinds.
NEW YORK, July 1, 2025 /PRNewswire/ -- Harvest Partners, LP ("Harvest") announced today that funds managed by Harvest have completed a majority acquisition of The Learning Experience ("TLE" or the ...
Acquisition expands Ingersoll Rand competencies and capabilities in high-growth end markets Purchase made at an attractive low-double-digit multiple with expected post-synergy multiple in the mid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results